Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medical Ikkou Group CoTSE:3353 +0.53%63 Days Payable is 43.06 as of Feb. 2026, which is 1% below its 10-year median of 43.35. GuruFocus rates TSE:3353 with a GF Score™ of 63/100 and a GF Value™ of 円3,534.01 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 509 Conglomerates companies, Medical Ikkou Group Co ranks worse than 65.23% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Conglomerates subindustry, Medical Ikkou Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Ikkou Group Co Days Payable vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Medical Ikkou Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Medical Ikkou Group Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medical Ikkou Group Co's Days Payable for the fiscal year that ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Ikkou Group Co (TSE:3353) has a Days Payable of 43.06 as of Feb. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medical Ikkou Group Co and its competitors. This is near median its historical median of 43.35. Over the past decade, Medical Ikkou Group Co's Days Payable has ranged from 41.12 to 49.67. According to the industry distribution chart, Medical Ikkou Group Co ranks #332 out of 509 companies in the Conglomerates industry, placing it in the top 65.2%.
Is Medical Ikkou Group Co's Days Payable too high?
Medical Ikkou Group Co's current Days Payable of 43.06 is near median its 10-year median of 43.35. Over the past 10 years, this metric has ranged from a low of 41.12 to a high of 49.67. The Conglomerates industry median Days Payable is 56.18. Medical Ikkou Group Co's value of 43.06 is 23.4% below this industry median. Based on the distribution chart, Medical Ikkou Group Co ranks #332 out of 509 companies in the Conglomerates industry, which is below the industry midpoint. Overall, Medical Ikkou Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's Days Payable compare to HON and MMM?
According to the Conglomerates industry distribution chart, Medical Ikkou Group Co ranks #332 out of 509 companies for Days Payable. This places Medical Ikkou Group Co in the lower half of its industry. The industry median Days Payable is 56.18. Medical Ikkou Group Co's value of 43.06 is 23.4% below this benchmark. Historically, Medical Ikkou Group Co's own Days Payable has ranged from 41.12 to 49.67 over the past decade. While the company's 10-year median is 43.35 vs. the industry median of 56.18, Medical Ikkou Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Conglomerates company?
The median Days Payable among Conglomerates companies is 56.18, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current Days Payable of 43.06 is 23.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medical Ikkou Group Co and its competitors. For the Conglomerates industry, the median Days Payable is 56.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current Days Payable is 43.06, which is near median its own 10-year median of 43.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,534.01, compared to a current price of 円2,841.00 — trading 19.6% below its estimated fair value. The current Days Payable is 43.06, which is near median its 10-year median of 43.35 and 23.4% below the Conglomerates industry median of 56.18. Medical Ikkou Group Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current Days Payable is 43.06 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued.
The current stock price of 円2,841.00 is trading 19.6% below its estimated GF Value™ of 円3,534.01.
GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.
Key valuation signals for TSE:3353:
Days Payable: 43.06 (near median its 10-year median of 43.35)
GF Value™: 円3,534.01 vs. price of 円2,841.00 (19.6% below fair value)
Industry Position: 23.4% below the Conglomerates median (#332 of 509)
No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
63GF Score
Get the complete analysis for TSE:3353
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3353 has been successfully added to your 
